title: Plasma and urinary leukotrienes in sickle cell disease: possible role in the inflammatory process.
abstract: Sickle cell (HbSS) disease is associated with rheological and inflammatory stresses within the microcirculation. In order to determine the role of leukotrienes in the inflammatory processes in HbSS patients, we analysed plasma and urine levels of leukotrienes (LT); LTB4, LTC4, LTD4, and LTE4 as indicators of their in vivo metabolism. Plasma and urine level samples of 15 HbSS patients in steady-state and age-matched healthy, homozygous (HbAA) controls were extracted for leukotrienes and quantitated by HPLC. Control plasma level of leukotrienes (mean +/- SEM, ng ml-1) were: LTB4, 8.95 +/- 0.26; LTC4, 7.24 +/- 0.21; LTD4, 11.42 +/- 0.40; and LTE4, 14.51 +/- 0.50. Corresponding values for HbSS patients were: LTB4, 6.15 +/- 0.42; LTC4, 13.61 +/- 1.45; LTD4, 6.44 +/- 0.51 and LTE4, 4.97 +/- 0.37. The differences were significant at P < 0.05. Urine levels (mean +/- SEM, ng mmol-1 creatinine), for controls were: LTB4, 10.60 +/- 0.35; LTC4, 360.0 +/- 9.82. Values for HbSS urine were: LTB4, 27.50 +/- 3.33; LTC4, 356.0 +/- 17.87; LTD4, 69.90 +/- 14.51. LTD4 was not detected in control urine. These results suggest that sickle cell patients may exhibit impaired ability to catabolize LTC4 in plasma during steady state conditions. This altered metabolism may contribute to the persistent stress of the microcirculation, and is probably related to the abnormal microvascular rheology of sickle blood cells.
authors.affiliation: Department of Pediatrics, Harbor-UCLA Medical Center, Torrance 90502.
authors.forename: B O
authors.initials: BO
authors.lastname: Ibe
authors.forename: J
authors.initials: J
authors.lastname: Kurantsin-Mills
authors.forename: J U
authors.initials: JU
authors.lastname: Raj
authors.forename: L S
authors.initials: LS
authors.lastname: Lessin
mesh_terms: D000328:Adult; D000755:Anemia, Sickle Cell / Q000097:blood* / Q000473:pathology / Q000652:urine*; D002448:Cell Adhesion; D004730:Endothelium, Vascular / Q000378:metabolism / Q000473:pathology; D005260:Female; D006801:Humans; D007249:Inflammation / Q000097:blood / Q000473:pathology / Q000652:urine; D007962:Leukocytes / Q000473:pathology; D007975:Leukotriene B4 / Q000097:blood / Q000652:urine; D017997:Leukotriene C4 / Q000097:blood / Q000652:urine; D017998:Leukotriene D4 / Q000097:blood / Q000652:urine; D017999:Leukotriene E4 / Q000097:blood / Q000652:urine; D015289:Leukotrienes / Q000097:blood* / Q000652:urine*; D008297:Male; D008875:Middle Aged
chemical_list: D015289:Leukotrienes; D007975:Leukotriene B4; D017997:Leukotriene C4; D017998:Leukotriene D4; D017999:Leukotriene E4